1. National Institute for Health and Clinical ExcellenceNICE technology appraisal guidance 188: human growth hormone (somatropin) for the treatment of growth failure in children 2010 (review). https://www.nice.org.uk/guidance/TA188. Accessed November 11, 2016.
2. Observations of nonadherence to recombinant human growth hormone therapy in clinical practice;Haverkamp;Clin Ther,2008
3. Monitoring of concordance in growth hormone therapy;Kapoor;Arch Dis Child,2008
4. Optimizing growth hormone efficacy: an evidence-based analysis;Lustig;Horm Res,2004
5. World Health OrganizationAdherence to long-term therapies: evidence for action 2003. http://apps.who.int/iris/bitstream/10665/42682/1/9241545992.pdf. Accessed November 11, 2016.